Cardiac Failure clinical trials at UCSF
1 in progress, 1 open to new patients
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
open to eligible people ages 18 years and up
The purpose of the study is to evaluate the safety and effectiveness of the ReliantHeart HeartAssist 5® VAD System in patients listed for heart transplantation and at risk of death from refractory end-stage heart failure.
San Francisco, California and other locations